Medtronic is focused in providing a complete cardiovascular portfolio to physicians to treat their patients’ individual needs.

Breaking News from TCT

Sustained, Powerful Outcomes
In Over 5,000 Resolute Patients

Recent Publications

*The information in this article is not intended to promote any of the uses not specifically within the product indications. Although over 66% of the trial participation represented complex patients and/or lesions representative of real-world clinical practice, it is important to note that Resolute DES is not specifically indicated for all these complex characteristics.